Example: marketing
MODULE 2.4 NONCLINICAL OVERVIEW
CONFIDENTIAL m2.4. Nonclinical Overview 2012N153960_00 7 1. OVERVIEW OF THE NONCLINICAL TESTING STRATEGY 1.1. Introduction Dolutegravir is a novel, potent and selective orally bioavailable integrase inhibitor.
Tags:
Information
Domain:
Source:
Link to this page:
Related search queries
Juvenile, Of juvenile, School Re-enrollment and Transition, School Re-enrollment and Transition from Juvenile Justice Facilities, TREATMENT OF JUVENILE OFFENDERS AND THEIR, Treatment of juvenile offenders and their reintegration, An Overview of Alternative Education, Legacy: Six Strategies for Sustainability, Legacy: Six Strategies for Sustainability Introduction